New Zealand’s Fonterra ... agreed to sell its 50% stake in DFE Pharma for NZ$633 million ($400.37 million) as the world’s biggest dairy exporter trims its overseas portfolio to focus on domestic business.
— Reuters
It is a leading global excipients manufacturer for the pharmaceutical industry. DFE Pharma has operations in Europe, India and New Zealand, is headquartered in Germany and has presence in over 100 countries. Fonterra is a global dairy nutrition co-operative headquartered in New Zealand owned by 10,000 farmers. It is the world’s largest dairy exporter and employs around 22,000 people globally, according to PDS.
The primary jurisdiction of the deal was
PDS Legal advised
Also advising was
Rothschild & Co, Freshfields Bruckhaus Deringer and KPMG acted for
2019-09-25
Deal value: NZ$ 633 m
This deal report is based on a firm's press release and may be only partially complete. Some firms or names of advisers may be therefore be missing.